BioSpace News Archive

BELLUS Health Inc. reported its financial and operating results for the quarter ended March 31, 2023.

Sotera Health Company announced that Chairman and CEO Michael B. Petras, Jr. will participate in an open forum discussion at the 2023 RBC Capital Markets Global Healthcare Conference on Tuesday, May 16, 2023 at 4:35 pm Eastern.

Ensysce Biosciences, Inc. announced the closing of the previously announced public offering of an aggregate of 1,800,876 shares of its common stock, Series A-1 warrants to purchase up to 1,800,876 shares of common stock and Series A-2 warrants to purchase 1,800,876 shares of common stock, at a combined public offering price of $3.887 per share and accompanying warrants.

CEL-SCI Corporation reported financial results for the quarter ended March 31, 2023, as well as key clinical and corporate developments.

Aligos Therapeutics, Inc. announced that it has entered into a research collaboration and development agreement with Xiamen Amoytop Biotech Co. Ltd. for the use of Aligos’ oligonucleotide platform to discover, research and develop oligonucleotides for the treatment of liver diseases in the Greater China territory.

RELIEF THERAPEUTICS Holding SA announced that it has filed its 2022 Annual Report on Form 20-F with the U.S. Securities and Exchange Commission.